A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism	Adenoma, Islet Cell, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Nutritional and Metabolic Diseases, adenoma, connective tissue neoplasm, endocrine system disorder, epithelial neoplasm, fibrosarcoma, glucose metabolism disease, hyperinsulinism, hypoglycemia, liposarcoma, malignant endocrine neoplasm, metabolic disease, neoplasm, neuroendocrine neoplasm, neuroepithelial neoplasm, pancreas disorder, pancreatic insulinoma, pancreatic neoplasm, primitive neuroectodermal tumor, sarcoma	Recruiting	Phase 3	2026-09-28		NCT06881992

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Rezolute	2

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.